Across TCGA pan-cancer cohorts, EGFEM1P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated EGFEM1P data layer compared with 24 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher EGFEM1P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated EGFEM1P expression acts as an unfavorable survival marker.

THYM are the cancer types where EGFEM1P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: EGFEM1P tumor-vs-normal RNA expression · all EGFEM1P data types